BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4617868)

  • 1. The relation of bioavailability to the dissolution rate of experimentally produced digoxin tablets.
    Johnson BF; Greer H; McCrerie JA; Bye C; Fowle AS
    Postgrad Med J; 1974 Nov; 50 Suppl 6():48-52. PubMed ID: 4617868
    [No Abstract]   [Full Text] [Related]  

  • 2. Digoxin tablets--a review of the bioavailability problems.
    Sim SK
    Am J Hosp Pharm; 1976 Jan; 33(1):44-8. PubMed ID: 1266866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of digoxin from tablets. III. Availability of digoxin in man from preparations with different dissolution rate.
    Nyberg L; Andersson KE; Bertler A
    Acta Pharm Suec; 1974 Nov; 11(5):471-92. PubMed ID: 4440505
    [No Abstract]   [Full Text] [Related]  

  • 4. [Improved bioavailability of Israeli digoxin tablets with increased dissolution rates].
    Halkin H; Farfel Z; Saginer P; Millman P; Gibbor Y
    Harefuah; 1977 Oct; 93(7-8):189-91. PubMed ID: 924245
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers.
    Bansinath M; Ghosh SS; Shafiqa A; Shukla VK; Chopra KS; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):30-3. PubMed ID: 3957487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioavailability of digoxin from tablets. I. In vitro characterization of digoxin tablets.
    Nyberg L; Bratt L; Forsgren A; Hugosson S
    Acta Pharm Suec; 1974 Nov; 11(5):447-58. PubMed ID: 4440503
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioavailability of digoxin from tablets. IV. Urinary excretion of digoxin during multiple dose treatment.
    Nyberg L; Andersson KE; Fagerström PO
    Acta Pharm Suec; 1977; 14(2):119-36. PubMed ID: 906830
    [No Abstract]   [Full Text] [Related]  

  • 8. The biological availability of very rapidly dissolving digoxin tablets.
    Shaw TR; Raymond K; Greenwood H
    Postgrad Med J; 1974 Nov; 50 Suppl 6():55-9. PubMed ID: 4459890
    [No Abstract]   [Full Text] [Related]  

  • 9. The bioavailability of other digoxin preparations compared with tablets.
    Johnson BF; Bye C; Lader S
    Postgrad Med J; 1974 Nov; 50 Suppl 6():62-6. PubMed ID: 4459892
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioavailability of ciprofloxacin tablets in humans and its correlation with the dissolution rates.
    Khan MK; Khan MF; Khan H; Mustafa G
    Pak J Pharm Sci; 2009 Jul; 22(3):329-34. PubMed ID: 19553184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability of digoxin in capsules.
    Padeletti L; Brat A
    Int J Clin Pharmacol Biopharm; 1978 Jul; 16(7):320-2. PubMed ID: 669878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rate of tetracycline dissolution from tablets and capsules and the biological availability of the antibiotic].
    Okhotnikova VF; Grakovskaia LK; Koroleva VG; Minasova GS; Zak IR
    Antibiotiki; 1976 Aug; 21(8):719-21. PubMed ID: 999252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between dissolution rate and bioavailability of paracetamol tablet.
    Huang XP; Wan XX; Liu Q
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Apr; 23(4):367-8, 371. PubMed ID: 12697478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of nalidixic acid from uncoated tablets in humans--Part I: Correlation with the dissolution rates of the tablets.
    Ogata H; Aoyagi N; Kaniwa K; Shibazaki T; Ejima A; Takasugi N; Mafune E; Hayashi T; Suwa K
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):175-83. PubMed ID: 6715086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of digoxin tablets in relation to their dissolution in vitro.
    Ylitalo P; Wilen G; Lundell S
    J Pharm Sci; 1975 Jul; 64(7):1264-6. PubMed ID: 1151696
    [No Abstract]   [Full Text] [Related]  

  • 17. Dissolution properties of digoxin tablets marketed in the Republic of Ireland.
    Corrigan OI; Timoney RF
    Ir Med J; 1976 Feb; 69(3):60. PubMed ID: 1025046
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of particle size on the bioavailability of digoxin.
    Jounela AJ; Pentikäinen PJ; Sothmann A
    Eur J Clin Pharmacol; 1975 Jun; 8(5):365-70. PubMed ID: 1233237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical and dissolution characteristics and bio-availability of five brands of digoxin tablets.
    Fletcher S; Summers RS
    S Afr Med J; 1980 Apr; 57(14):530-3. PubMed ID: 7368019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equivalent bioavailability from digoxin elixir and rapid-dissolution tablets.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    JAMA; 1974 Sep; 229(13):1774-6. PubMed ID: 4479121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.